HEADER VIRAL PROTEIN 11-AUG-23 7GNB TITLE GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH INHIBITORS TITLE 2 FROM THE COVID MOONSHOT -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN TITLE 3 PROTEASE IN COMPLEX WITH EDG-MED-EE636701-1 (MPRO-P2468) COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3CL-PRO, 3CLP, MAIN PROTEASE, MPRO, NON-STRUCTURAL PROTEIN COMPND 5 5, NSP5, SARS CORONAVIRUS MAIN PROTEINASE; COMPND 6 EC: 3.4.22.69; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: REP, 1A-1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DIAMOND LIGHT SOURCE, I04-1, COVID MOONSHOT, CMD, MPRO, FRAGMENT KEYWDS 2 SCREENING, PANDDA, XCHEMEXPLORER, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR D.FEARON,A.AIMON,J.C.ASCHENBRENNER,B.H.BALCOMB,F.K.R.BERTRAM, AUTHOR 2 J.BRANDAO-NETO,A.DIAS,A.DOUANGAMATH,L.DUNNETT,A.S.GODOY,T.J.GORRIE- AUTHOR 3 STONE,L.KOEKEMOER,T.KROJER,R.M.LITHGO,P.LUKACIK,P.G.MARPLES, AUTHOR 4 H.MIKOLAJEK,E.NELSON,C.D.OWEN,A.J.POWELL,V.L.RANGEL,R.SKYNER, AUTHOR 5 C.M.STRAIN-DAMERELL,W.THOMPSON,C.W.E.TOMLINSON,C.WILD,M.A.WALSH, AUTHOR 6 F.VON DELFT REVDAT 2 06-DEC-23 7GNB 1 JRNL REMARK REVDAT 1 08-NOV-23 7GNB 0 JRNL AUTH M.L.BOBY,D.FEARON,M.FERLA,M.FILEP,L.KOEKEMOER,M.C.ROBINSON, JRNL AUTH 2 J.D.CHODERA,A.A.LEE,N.LONDON,A.VON DELFT,F.VON DELFT, JRNL AUTH 3 H.ACHDOUT,A.AIMON,D.S.ALONZI,R.ARBON,J.C.ASCHENBRENNER, JRNL AUTH 4 B.H.BALCOMB,E.BAR-DAVID,H.BARR,A.BEN-SHMUEL,J.BENNETT, JRNL AUTH 5 V.A.BILENKO,B.BORDEN,P.BOULET,G.R.BOWMAN,L.BREWITZ,J.BRUN, JRNL AUTH 6 S.BVNBS,M.CALMIANO,A.CARBERY,D.W.CARNEY,E.CATTERMOLE, JRNL AUTH 7 E.CHANG,E.CHERNYSHENKO,A.CLYDE,J.E.COFFLAND,G.COHEN, JRNL AUTH 8 J.C.COLE,A.CONTINI,L.COX,T.I.CROLL,M.CVITKOVIC,S.DE JONGHE, JRNL AUTH 9 A.DIAS,K.DONCKERS,D.L.DOTSON,A.DOUANGAMATH,S.DUBERSTEIN, JRNL AUTH10 T.DUDGEON,L.E.DUNNETT,P.EASTMAN,N.EREZ,C.J.EYERMANN, JRNL AUTH11 M.FAIRHEAD,G.FATE,O.FEDOROV,R.S.FERNANDES,L.FERRINS, JRNL AUTH12 R.FOSTER,H.FOSTER,L.FRAISSE,R.GABIZON,A.GARCIA-SASTRE, JRNL AUTH13 V.O.GAWRILJUK,P.GEHRTZ,C.GILEADI,C.GIROUD,W.G.GLASS, JRNL AUTH14 R.C.GLEN,I.GLINERT,A.S.GODOY,M.GORICHKO,T.GORRIE-STONE, JRNL AUTH15 E.J.GRIFFEN,A.HANEEF,S.HASSELL HART,J.HEER,M.HENRY,M.HILL, JRNL AUTH16 S.HORRELL,Q.Y.J.HUANG,V.D.HULIAK,M.F.D.HURLEY,T.ISRAELY, JRNL AUTH17 A.JAJACK,J.JANSEN,E.JNOFF,D.JOCHMANS,T.JOHN,B.KAMINOW, JRNL AUTH18 L.KANG,A.L.KANTSADI,P.W.KENNY,J.L.KIAPPES,S.O.KINAKH, JRNL AUTH19 B.KOVAR,T.KROJER,V.N.T.LA,S.LAGHNIMI-HAHN,B.A.LEFKER,H.LEVY, JRNL AUTH20 R.M.LITHGO,I.G.LOGVINENKO,P.LUKACIK,H.B.MACDONALD, JRNL AUTH21 E.M.MACLEAN,L.L.MAKOWER,T.R.MALLA,P.G.MARPLES,T.MATVIIUK, JRNL AUTH22 W.MCCORKINDALE,B.L.MCGOVERN,S.MELAMED,K.P.MELNYKOV, JRNL AUTH23 O.MICHURIN,P.MIESEN,H.MIKOLAJEK,B.F.MILNE,D.MINH,A.MORRIS, JRNL AUTH24 G.M.MORRIS,M.J.MORWITZER,D.MOUSTAKAS,C.E.MOWBRAY, JRNL AUTH25 A.M.NAKAMURA,J.B.NETO,J.NEYTS,L.NGUYEN,G.D.NOSKE, JRNL AUTH26 V.OLEINIKOVAS,G.OLIVA,G.J.OVERHEUL,C.D.OWEN,R.PAI,J.PAN, JRNL AUTH27 N.PARAN,A.M.PAYNE,B.PERRY,M.PINGLE,J.PINJARI,B.POLITI, JRNL AUTH28 A.POWELL,V.PSENAK,I.PULIDO,R.PUNI,V.L.RANGEL,R.N.REDDI, JRNL AUTH29 P.REES,S.P.REID,L.REID,E.RESNICK,E.G.RIPKA,R.P.ROBINSON, JRNL AUTH30 J.RODRIGUEZ-GUERRA,R.ROSALES,D.A.RUFA,K.SAAR,K.S.SAIKATENDU, JRNL AUTH31 E.SALAH,D.SCHALLER,J.SCHEEN,C.A.SCHIFFER,C.J.SCHOFIELD, JRNL AUTH32 M.SHAFEEV,A.SHAIKH,A.M.SHAQRA,J.SHI,K.SHURRUSH,S.SINGH, JRNL AUTH33 A.SITTNER,P.SJO,R.SKYNER,A.SMALLEY,B.SMEETS,M.D.SMILOVA, JRNL AUTH34 L.J.SOLMESKY,J.SPENCER,C.STRAIN-DAMERELL,V.SWAMY,H.TAMIR, JRNL AUTH35 J.C.TAYLOR,R.E.TENNANT,W.THOMPSON,A.THOMPSON,S.TOMASIO, JRNL AUTH36 C.W.E.TOMLINSON,I.S.TSURUPA,A.TUMBER,I.VAKONAKIS, JRNL AUTH37 R.P.VAN RIJ,L.VANGEEL,F.S.VARGHESE,M.VASCHETTO,E.B.VITNER, JRNL AUTH38 V.VOELZ,A.VOLKAMER,M.A.WALSH,W.WARD,C.WEATHERALL,S.WEISS, JRNL AUTH39 K.M.WHITE,C.F.WILD,K.D.WITT,M.WITTMANN,N.WRIGHT, JRNL AUTH40 Y.YAHALOM-RONEN,N.K.YILMAZ,D.ZAIDMANN,I.ZHANG,H.ZIDANE, JRNL AUTH41 N.ZITZMANN,S.N.ZVORNICANIN JRNL TITL OPEN SCIENCE DISCOVERY OF POTENT NONCOVALENT SARS-COV-2 MAIN JRNL TITL 2 PROTEASE INHIBITORS. JRNL REF SCIENCE V. 382 O7201 2023 JRNL REFN ESSN 1095-9203 JRNL PMID 37943932 JRNL DOI 10.1126/SCIENCE.ABO7201 REMARK 2 REMARK 2 RESOLUTION. 1.67 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.4 (20-OCT-2021) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.67 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 58.8 REMARK 3 NUMBER OF REFLECTIONS : 49287 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 2533 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 51 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.67 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.80 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 5.90 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 986 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2879 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 932 REMARK 3 BIN R VALUE (WORKING SET) : 0.2881 REMARK 3 BIN FREE R VALUE : 0.2848 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.48 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 54 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4716 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 115 REMARK 3 SOLVENT ATOMS : 511 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.31440 REMARK 3 B22 (A**2) : 3.86590 REMARK 3 B33 (A**2) : -0.55160 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.280 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.196 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.161 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.182 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.156 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4931 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6701 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1644 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 886 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4931 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 628 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4360 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.94 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.68 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.01 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -8.1062 -6.8505 27.0766 REMARK 3 T TENSOR REMARK 3 T11: -0.1135 T22: 0.0631 REMARK 3 T33: -0.0456 T12: -0.0433 REMARK 3 T13: 0.0125 T23: -0.0223 REMARK 3 L TENSOR REMARK 3 L11: 1.3845 L22: 0.2456 REMARK 3 L33: 0.8779 L12: 0.3564 REMARK 3 L13: 0.6299 L23: 0.2007 REMARK 3 S TENSOR REMARK 3 S11: -0.0073 S12: -0.0458 S13: 0.0023 REMARK 3 S21: 0.0376 S22: -0.0060 S23: 0.0535 REMARK 3 S31: 0.0489 S32: 0.0367 S33: 0.0133 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 4.4048 0.8864 5.2894 REMARK 3 T TENSOR REMARK 3 T11: -0.0692 T22: -0.0140 REMARK 3 T33: -0.0602 T12: 0.0014 REMARK 3 T13: 0.0158 T23: -0.0177 REMARK 3 L TENSOR REMARK 3 L11: 0.3280 L22: 1.0243 REMARK 3 L33: 2.5416 L12: 0.1452 REMARK 3 L13: -0.2760 L23: 0.9267 REMARK 3 S TENSOR REMARK 3 S11: 0.0799 S12: -0.0269 S13: -0.0011 REMARK 3 S21: -0.0557 S22: -0.0090 S23: 0.0568 REMARK 3 S31: 0.0206 S32: 0.1392 S33: -0.0709 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7GNB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1001406397. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-NOV-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.91788 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49299 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.671 REMARK 200 RESOLUTION RANGE LOW (A) : 72.602 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 58.7 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.67 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.88 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 0.92900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 4K, 5% DMSO, 0.1M MES PH 6.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.01050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.16100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 50.55150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.16100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.01050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 50.55150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 306 REMARK 465 GLN B 306 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 501 O HOH A 638 1.98 REMARK 500 O ASP A 155 O HOH A 501 2.19 REMARK 500 O HOH A 602 O HOH B 625 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -131.13 57.97 REMARK 500 ASN A 84 -124.16 59.42 REMARK 500 TYR A 154 -145.88 71.42 REMARK 500 PRO A 184 42.32 -83.46 REMARK 500 ASP B 33 -130.46 58.02 REMARK 500 ASN B 51 77.60 -159.57 REMARK 500 ASN B 84 -124.67 59.34 REMARK 500 TYR B 154 -109.25 66.83 REMARK 500 PRO B 184 45.29 -83.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 710 DISTANCE = 6.10 ANGSTROMS REMARK 525 HOH B 711 DISTANCE = 6.68 ANGSTROMS REMARK 525 HOH B 712 DISTANCE = 7.48 ANGSTROMS DBREF 7GNB A 1 306 UNP P0DTD1 R1AB_SARS2 3264 3569 DBREF 7GNB B 1 306 UNP P0DTD1 R1AB_SARS2 3264 3569 SEQRES 1 A 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 A 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 A 306 LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO SEQRES 4 A 306 ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO SEQRES 5 A 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN SEQRES 6 A 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 A 306 GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL SEQRES 8 A 306 ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 A 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 A 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 A 306 ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 A 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 A 306 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 A 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR SEQRES 15 A 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 A 306 THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU SEQRES 17 A 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 A 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 A 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 A 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 A 306 VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN SEQRES 22 A 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU SEQRES 23 A 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 A 306 CYS SER GLY VAL THR PHE GLN SEQRES 1 B 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 B 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 B 306 LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO SEQRES 4 B 306 ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO SEQRES 5 B 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN SEQRES 6 B 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 B 306 GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL SEQRES 8 B 306 ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 B 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 B 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 B 306 ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 B 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 B 306 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 B 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR SEQRES 15 B 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 B 306 THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU SEQRES 17 B 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 B 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 B 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 B 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 B 306 VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN SEQRES 22 B 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU SEQRES 23 B 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 B 306 CYS SER GLY VAL THR PHE GLN HET DMS A 401 4 HET DMS A 402 4 HET DMS A 403 4 HET DMS A 404 4 HET CL A 405 1 HET RW0 A 406 35 HET DMS A 407 4 HET DMS A 408 4 HET DMS A 409 4 HET DMS B 401 4 HET RW0 B 402 35 HET DMS B 403 4 HET DMS B 404 4 HET DMS B 405 4 HETNAM DMS DIMETHYL SULFOXIDE HETNAM CL CHLORIDE ION HETNAM RW0 (3R,4S)-6-CHLORO-N-[7-(METHANESULFONYL)ISOQUINOLIN-4- HETNAM 2 RW0 YL]-3-METHYL-2-[2-(METHYLAMINO)-2-OXOETHYL]-1-OXO-1,2, HETNAM 3 RW0 3,4-TETRAHYDROISOQUINOLINE-4-CARBOXAMIDE FORMUL 3 DMS 11(C2 H6 O S) FORMUL 7 CL CL 1- FORMUL 8 RW0 2(C24 H23 CL N4 O5 S) FORMUL 17 HOH *511(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 SER A 46 LEU A 50 5 5 HELIX 4 AA4 ASN A 53 ARG A 60 1 8 HELIX 5 AA5 SER A 62 HIS A 64 5 3 HELIX 6 AA6 ILE A 200 ASN A 214 1 15 HELIX 7 AA7 THR A 226 MET A 235 1 10 HELIX 8 AA8 LYS A 236 ASN A 238 5 3 HELIX 9 AA9 THR A 243 LEU A 250 1 8 HELIX 10 AB1 LEU A 250 GLY A 258 1 9 HELIX 11 AB2 ALA A 260 GLY A 275 1 16 HELIX 12 AB3 THR A 292 CYS A 300 1 9 HELIX 13 AB4 SER B 10 GLY B 15 1 6 HELIX 14 AB5 HIS B 41 CYS B 44 5 4 HELIX 15 AB6 THR B 45 LEU B 50 1 6 HELIX 16 AB7 ASN B 53 ARG B 60 1 8 HELIX 17 AB8 SER B 62 HIS B 64 5 3 HELIX 18 AB9 ILE B 200 ASN B 214 1 15 HELIX 19 AC1 THR B 226 TYR B 237 1 12 HELIX 20 AC2 THR B 243 LEU B 250 1 8 HELIX 21 AC3 LEU B 250 GLY B 258 1 9 HELIX 22 AC4 ALA B 260 GLY B 275 1 16 HELIX 23 AC5 THR B 292 CYS B 300 1 9 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 PHE A 66 ALA A 70 -1 N VAL A 68 O LEU A 75 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 89 N VAL A 36 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N SER A 81 O LYS A 88 SHEET 1 AA2 5 TYR A 101 PHE A 103 0 SHEET 2 AA2 5 VAL A 157 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA2 5 VAL A 148 ASN A 151 -1 N ASN A 151 O SER A 158 SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O TYR A 126 N VAL A 114 SHEET 1 AA3 3 TYR A 101 PHE A 103 0 SHEET 2 AA3 3 VAL A 157 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 AA4 7 VAL B 73 LEU B 75 0 SHEET 2 AA4 7 PHE B 66 ALA B 70 -1 N VAL B 68 O LEU B 75 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 AA4 7 THR B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 AA4 7 VAL B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 AA4 7 VAL B 86 VAL B 91 -1 O LEU B 89 N VAL B 36 SHEET 7 AA4 7 VAL B 77 GLN B 83 -1 N SER B 81 O LYS B 88 SHEET 1 AA5 5 LYS B 100 PHE B 103 0 SHEET 2 AA5 5 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA5 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 AA5 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 AA5 5 SER B 121 ALA B 129 -1 O TYR B 126 N VAL B 114 SHEET 1 AA6 3 LYS B 100 PHE B 103 0 SHEET 2 AA6 3 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA6 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 CRYST1 68.021 101.103 104.322 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014701 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009891 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009586 0.00000